Exit Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Exit Wealth Advisors's BMY Position: Q3 2026 in Review
Exit Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 53,008 shares — an estimated $3.05M sold.
Exit Wealth Advisors first reported a position in BMY in Q4 2025 and held it in 3 quarters. The position peaked at $3.05M in Q2 2026. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Exit Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- Exit Wealth Advisors sold 53,008 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.05M.
- Exit Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and held it in 3 quarters.
- Exit Wealth Advisors's Bristol-Myers Squibb position peaked at $3.05M in Q2 2026.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Exit Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.